Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP refers Moxxor, Siglas to FTC

This article was originally published in The Tan Sheet

Executive Summary

The Electronic Retailing Self-Regulation Program refers Moxxor, the omega-3 dietary supplement, to the Federal Trade Commission after the product's manufacturer of the same name failed to respond to an inquiry about its product, ERSP says Oct. 27. ERSP conducted a review of the firm's online advertising after receiving an anonymous complaint, and later requested substantiation for performance, endorsement, superiority and testimonial claims. ERSP also refers Siglas Inc. to the FTC for not substantiating performance and exclusivity claims for the Sauna Twin Multi-Lipo Reductor. Siglas failed to submit a "substantive response" to ERSP despite multiple requests and a 10-day deadline extension, ERSP said in a separate Oct. 27 release

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel